J8522 Capecitabine - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Capecitabine

Brand Name:

Multiple

Strength:

50mg

HCPCS:

J8522

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antimetabolite

Minor Drug Class:

Oral (Y/N):

Yes

FDA Approval Year:

2005

FDA Discontinuation Year:

CMS Effective Date:

Sept. 11, 2024

CMS Discontinuation Date:

Status:

In Use